William P. Sheridan
2014
In 2014, William P. Sheridan earned a total compensation of $2.4M as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 95% increase compared to previous year.
Compensation breakdown
| Bonus | $67,352 |
|---|---|
| Non-Equity Incentive Plan | $122,956 |
| Option Awards | $1,155,223 |
| Salary | $436,433 |
| Stock Awards | $583,200 |
| Other | $25,430 |
| Total | $2,390,594 |
Sheridan received $1.2M in option awards, accounting for 48% of the total pay in 2014.
Sheridan also received $67.4K in bonus, $123K in non-equity incentive plan, $436.4K in salary, $583.2K in stock awards and $25.4K in other compensation.
Rankings
In 2014, William P. Sheridan's compensation ranked 3,832nd out of 13,032 executives tracked by ExecPay. In other words, Sheridan earned more than 70.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,832 out of 13,032 | 71st |
Division Manufacturing | 1,354 out of 4,966 | 73rd |
Major group Chemicals And Allied Products | 437 out of 1,686 | 74th |
Industry group Drugs | 339 out of 1,365 | 75th |
Industry Biological Products, Except Diagnostic Substances | 55 out of 236 | 77th |
Source: SEC filing on April 11, 2016.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2014.